Fatty acid oxidation was studied in the presence of inhibitors of carnitine palmitoyltransferase I (CPT I), in normal and in peroxisome-proliferated rat hepatocytes. The oxidation decreased in mitochondria, as expected, but in peroxisomes it increased. These two effects were seen, in variable proportions, with (+)-decanoylcarnitine, 2-tetradecylglycidic acid (TDGA) and etomoxir. The decrease in mitochondrial oxidation (ketogenesis) affected saturated fatty acids with 12 or more carbon atoms, whereas the increase in peroxisomal oxidation (H202 production) affected saturated fatty acids with 8 or more carbon atoms. The peroxisomal increase was sensitive to chlorpromazine, a peroxisomal inhibitor. To study possible mechanisms, palmitoyl-, octanoyl-and acetyl-carnitine acyltransferase activities were measured, in homogenates and in subcellular fractions from control and TDGA-treated cells. The palmitoylcarnitine acyltransferase was inhibited, as expected, but the octanoyltransferase activity also decreased. The CoA derivative of TDGA was synthesized and tentatively identified as being responsible for inhibition of the octanoylcarnitine acyltransferase. These results show that inhibitors of the mitochondrial CPT I -may, also inhibit the peroxisomal octanoyl transferase; they also support the hypothesis that the octanoyltransferase has the capacity to control or regulate peroxisomal fatty acid oxidation.
INTRODUCTION
Fatty acid f-oxidation in liver cells occurs in mitochondria and in peroxisomes. The two oxidative systems exhibit considerable overlap in substrate specificity (Lazarow & de Duve, 1976; Tolbert, 1981) a fact that has hindered efforts to differentiate the role of each. Observations on inherited peroxisomal disorders have allowed identification of several substrates, very-long-chain fatty acids and others, which require peroxisomes for their oxidation (Wilson et al., 1988; Lazarow & Moser, 1989) . In mitochondria, fatty acid oxidation is regulated by a mechanism in which CPT I, a mitochondrial enzyme (Bremer, 1983) , plays a central role (McGarry & Foster, 1980) . Several CPT I inhibitors, which characteristically inhibit ketogenesis, are available and allow study of the role of mitochondria in situ, in cells or in organisms Tutwiler et al., 1981; Declercq et al., 1987) . In contrast, short-term regulatory mechanisms other than substrate availability have not been characterized in peroxisomes at a molecular level. These organelles contain carnitine acyltransferases for medium-and short-chain fatty acids (COT and CAT) (Markwell et al., 1973; Leighton et al., 1982; Miyazawa et al., 1983) , enzymes for which no physiological role has been firmly established (Bieber, 1988) . Pharmacologically, it is possible to inhibit selectively the oxidation of fatty acids in peroxisomes, but the mechanism of this effect is not known .
To evaluate the role of peroxisomes in whole cells, under conditions in which the mitochondrial oxidation of fatty acids is depressed, the activity of both systems was measured simultaneously, in normal and in peroxisome-proliferated rat hepatocytes treated with CPT I inhibitors.
EXPERIMENTAL Hepatocytes and incubations
The isolated hepatocytes were prepared by established procedures, as previously described , from male Sprague-Dawley rats (200-250 g) , fed ad libitum with either standard pelleted diet, or for 1-2 weeks with pellets containing 50 mg of ciprofibrate/kg or 750 mg of bezafibrate/kg. The rats were fasted overnight before preparation of hepatocytes. The viability of the hepatocytes used was 94.4+ 1.5 %, estimated from Trypan Blue exclusion. For the incubations, run in duplicate or in triplicate, peroxisome-proliferated hepatocytes equivalent to approx. 1.5 mg of protein, or normal hepatocytes (approx. 4.5 mg of protein) were incubated in 1 ml for 20 min in plastic vials at 37°C under 02/CO2 (19:1). The medium contained 120 mM-NaCl, 4.8 mM-KCI, 2.0 mM-CaCl2, 1.2 mM-KH2PO4, 1.2 mM-MgSO4, 25 mM-NaHCO3, 50 mM-methanol, 10 mMsemicarbazide, 0.17 mm fatty-acid-free BSA and 0.5 mm fatty acid. The inhibitors were added in methanol. When preincubation of the cells was required, the reaction was started by addition of the substrate, otherwise by addition of cells. The reaction was stopped with 0.4 ml of cold 30 % (w/v) trichloroacetic acid. Blanks, without exogenous substrate but with fatty-acid-free BSA, were routinely incubated for 0 and 20 min to correct for endogenous activity. For H202 measurements, 0.5 ml of the acid supernatant was mixed with 0.5 ml of Nash (1953) (Williamson et al., 1962) . Controls were performed to evaluate the effect on ketogenesis of methanol and semicarbazide, at the concentrations employed for the assays: methanol does not affect it; semicarbazide, with or without methanol, exerts a minor inhibition, a 10-20 % decrease in total ketogenesis which preferentially affects the detection of acetoacetate.
Subcellular fractionation
For the fractionation experiments, hepatocytes from ciprofibrate-treated rats were employed. For each gradient a large-scale incubation was done in 25 ml, with palmitate as substrate, under the same conditions as used for the 1 ml standard incubations. The controls for the experiments in which the effect of a preincubation with TDGA was studied were performed with the same batch of hepatocytes. At the end of the large-scale incubations, a 1 ml sample was removed for measurements to validate the comparison of these observations with those with the standard I ml incubation volume. The remaining cells were washed with a solution of 0.25 M-sucrose/1 mM-EDTA/3 mmimidazole, pH 7.4, and were resuspended in 1 ml of the same solution. After homogenization with a Dounce glass homogenizer, an extract or postnuclear supernatant was prepared (de Duve et al., 1955) , of which 0.5 ml was layered on top of a continuous gradient of Nycodenz, ranging from 1.05 to 1.28 g/cm3. Centrifugation was done for 50 min at 40000 rev./min at 8°C in a VTi-65 Beckman rotor. The results are presented in accordance with standard procedures (Leighton et al., 1968) . Purified mitochondria were prepared as described by de Duve et al. (1955) . Purified peroxisomes were prepared as described previously , by using Nycodenz instead of metrizamide.
Enzyme assays
Carnitine acyltransferases were assayed radioactively or spectrophotometrically, as follows. The spectrophotometric assay was used in subcellular-fractionation and whole-homogenate measurements, as previously described (Leighton et.al., 1982) in the direction of acylcarnitine formation. For the assay, the fractions were diluted with 10 mM-sodium pyrophosphate, pH 8.1, containing 0.1 % sodium deoxycholate, and CoA release was monitored at 412 nm in the presence of DTNB. The final assay mixture, at pH 8.0 and 25°C, contained 2.5 mM-(-)-carnitine, 0.1 mM-acyl-CoA, 58 mM-Tris/HCl, 5 mm-sodium pyrophosphate, 0.05 % deoxycholate and 0.25 mM-DTNB. CPT I in isolated mitochondria was assayed radioactively, in the absence of detergent to prevent the contribution of CPT II, by using butan-l-ol extraction as described by Bremer (1981 Kawaguchi et al. (1981) , forming an acylimidazole in the first step. The TDGA-CoA was washed with diethyl ether, after acidification, and was recovered from the interphase where it precipitates.
Statistics
Measurements are presented as individual values, means, or as means + S.D.
RESULTS

Effect of CPT I inhibitors on the palmitate-dependent production of H202 and ketones by hepatocytes
The inhibition of CPT I should decrease ketogenesis from long-chain fatty acids. As shown in Table 1 , over 90 % of the ketogenesis induced by palmitate was suppressed by TDGA and etomoxir, two inactivating drugs. The inhibition by (+ )-decanoylcarnitine was moderate, probably because of the decreased sensitivity of CPT I to competitive inhibition in mitochondria from peroxisome-proliferated liver cells (Christiansen, 1978; Mannaerts et al., 1979) . In contrast, a large increase in palmitate-dependent peroxisomal H202 generation was seen with the three inhibitors employed. TDGA and etomoxir appeared equally active, and TDGA was selected for subsequent observations. Similar results (not shown) were obtained with hepatocytes from either ciprofibrate-or nafenopin-treated rats or from untreated rats. As shown in Fig. l , the effect of TDGA (Fig. 2) . In contrast, the production of H202was enhanced 2-fold or more with C80 and with longer fatty acids (Fig. 3) . The rate of H202 generation reflects that of acetyl-CoA generation in peroxisomes.
With C12:0, for example, it approaches the rate of mitochondrial ketogenesis. Yet a substrate-product relationship for the acetylCoA generated in peroxisomes and ketogenesis in mitochondria has not been found: free acetate and not ketones is the main product (Leighton et al., 1989) . In normal rat hepatocytes (Figs. 4 and 5) TDGA also inhibited ketogenesis, particularly from C12 0 and longer fatty acids, and increased the rate of H202 generation with C8.0 and longer fatty acids. As expected, the rates of H202 production are much lower than in peroxisomeproliferated cells.
To check if the enhancement of H202 generation induced by TDGA was sensitive to the peroxisomal inhibitor CPZ , observations were made with C12:0 and C16:0 as substrates ( Table 2 ). The C12 0-dependent H.02 generation was inhibited by almost 50% in both the absence and presence of TDGA. With C16:0, the effect was more pronounced.
Effect of TDGA on the activity of CPT, COT and CAT
The independent behaviour observed in the effects of TDGA and other drugs upon mitochondrial and peroxisomal activities raised the possibility that, in addition to the irreversible inhibition ofCPT I by TDGA-CoA (Kiorpes et al., 1984) carnitine esters (Tolbert, 1981; Leighton et al., 1982; Farrell & Bieber, 1983) . Inhibitors of CPT I might also act on COT or CAT in the cell, a possibility that has not been evaluated.
The activities of CPT, COT and CAT were measured in postnuclear supernatants or extracts from hepatocytes preincubated for 15 min with TDGA and from control cells, which were then incubated for 20 min with palmitate, to mimic the conditions for the fatty-acid-oxidation measurements. The extracts were subfractionated to correlate the activity of the transferases with their subcellular localization. The incubation with TDGA decreased total CPT activity by approx. 30 %. The insensitive fraction could correspond in part to activity of CPT II, located in the mitochondrial matrix and insensitive to TDGA. In addition, it was found that the activity of COT was also inhibited by 50% with TDGA. In contrast, the activity of CAT was stimulated by approx. 40 %. Since free TDGA would be removed during washing of the cells, the effects described apparently correspond to an irreversible inhibition, just as shown for CPT I (Declercq et al., 1985) . Since the substrate-specificity patterns for mitochondrial CPT and peroxisomal COT overlap, measurements were made in purified organelles to check if the inhibition detected with the substrate employed for COT, octanoyl-CoA, was due to COT inhibition or was the result of a partly inhibited CPT I acting on octanoyl-CoA. The results of these experiments are shown in Figs. 6 and 7. The subfractionation of an extract from peroxisome-proliferated hepatocytes incubated as indicated above (Fig. 6) showed a large fraction of catalase not bound to particles, and a small peak at around 1.20 g/cm3 that corresponds to peroxisomes. Adequate resolution was obtained among particle-bound catalase, the peroxisomal marker, and glutamate dehydrogenase, the mitochondrial marker. The endoplasmic-reticulum marker, NADPH-cytochrome c reductase, revealed a distribution that overlapped with cytosolic catalase and the mitochondrial peak. COT, in contrast with CAT and CPT, showed a bimodal distribution, with the larger fraction of the enzyme in the lowdensity peak, a distribution pattern common to peroxisomal enzymes in which only part of the enzyme is retained in the organelle, and the rest appears in the cytosol (Leighton et al., 1975) . After TDGA treatment, the activity of the transferases, modified as mentioned before, showed the same subcellular distribution pattern, with the characteristic bimodality of COT (Fig. 7) . If the 50 % inhibition of COT after TDGA had been due to inhibition of CPT I acting non-specifically on octanoyl-CoA, a selective decrease in the COT peak overlapping with mitochondria should have occurred. This was not seen in the experiment illustrated, nor in a duplicate set of experiments which gave the same inhibition with TDGA and the same pattern of subcellular distribution. When comparing the proportion of the transferases equilibrating at densities higher than the main mitochondrial peak, it can also be seen that the fraction of the activity present in the peroxisomal region is smaller for CPT and larger for COT and CAT, in agreement with previous data (Markwell et al., 1973; Bieber et al., 1981; Leighton et al., 1982) .
Effect of TDGA-CoA on mitochondrial CPT and peroxisomal
COT
To evaluate directly the evidence that TDGA inhibited COT, in addition to its well-established effect on CPT I, studies were
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Density (g/cm3) Fig. 6 . Subceliular distribution of carnitine acyltransferases (CAT, COT and CPT): isopycnic Nycodenz-density-gradient fractionation of an extract prepared from hepatocytes Hepatocytes from a ciprofibrate-treated rat were incubated and fractionated as described in the Experimental section. Standardized representation of the results in which the ordinate represents the frequency of the components for each fraction, Q/SQ * Ap, where Q represents the activity found in the fraction, IQ the total activity recovered in the fractions and Ap the increment in density of the gradient for each fraction. The abscissa illustrates the standardized density limits for each fraction. The Figure corresponds to one of two essentially equal gradients. The recoveries for CAT (C2), COT (C8) and CPT (C16) were 126%, 99% and 101 % respectively. made with isolated organelles. CPT and COT were measured in isolated mitochondria and peroxisomes, respectively, in the absence or presence of the inhibitor. Since the active inhibitor of CPT I is the CoA derivative of TDGA (Kiorpes et al., 1984) , TDGA-CoA was synthesized and inhibition assays were performed as described in the Experimental section. The measurement of H202 production, detected as formaldehyde released from catalase-mediated methanol peroxidation, allows estimation of the rate of peroxisomal fatty acid oxidation in intact cells Mannaerts et al., 1979) . The method is indirect, yet its results correlate well with measurements by organ differential spectrophotometry of catalase intermediates (Foerster et al., 1981) and with measurements in subcellular fractions Mannaerts et al., 1979) . The validity of this measurement has received further support in studies on the production of free acetate, the product of acetylCoA generated in peroxisomes (Leighton et al., 1989) .
The activity of mitochondria and peroxisomes in situ can be monitored by measuring ketogenesis and H202 generation. Since both organelles exhibit a considerable overlap in substrate specificity, and because peroxisomes in situ express only a minor Vol. 281 fraction of the optimum activity detected in cell-free systems (Leighton et al., 1982) (Bieber, 1988 ) the possible inhibition of COT by CPT I inhibitors cannot be rejected a priori. Accordingly, we explored the hypothesis that the inhibition of COT, in addition to CPT I, constitutes the basis of the opposite effects exerted by these drugs on peroxisomal and mitochondrial fatty acid oxidation.
COT inhibition and peroxisomal activity COT and CAT in the peroxisomes would participate in the transport of the products of fatty acid oxidation. This proposal is based on their substrate specificity and kinetic constants (Tolbert, 1981; Leighton et al., 1982; Farrell & Bieber, 1983; Farrell et al., 1984) . The properties of COT and its differentiation from those of CPT have been under experimental re-evaluation. Healy et al. (1988) studied the relationship between COT and the easily solubilized fraction of CPT, and Ramsay (1988) concluded that both activities correspond to different enzymes in bovine liver. In human liver, in addition to its presence in peroxisomes and mitochondria, COT is the only transferase detected in the endoplasmic reticulum , another localization for which a functional explanation is lacking. As stressed by Ramsay (1988) and Bieber (1988) , the overlap in enzyme specificity for the various transferases is partly responsible for the present ambiguity in this field.
To explain the increase in peroxisomal activity seen with CPT inhibitors, we propose that they also inhibit COT, a hypothesis based on two assumptions: that COT is indeed required to shuttle medium-chain acyl-CoAs from the peroxisome, and that an impairment of this process will favour further f-oxidation of the acyl-CoA retained in peroxisomes. A selective COT inhibitor, suitable for studies with hepatocytes, would allow a direct evaluation of this hypothesis, but apparently none is available. The inhibition reported with 2-bromopalmitate would not be specific for COT (Healy et al., 1988) . Malonyl-CoA apparently inhibits COT, in addition to CPT I (Saggerson & Carpenter, 1981; Lund & Bremer, 1983 ), a finding that raises intriguing regulatory possibilities, yet the sensitivity of COT to malonylCoA has been examined by others, with different results (Healy et al., 1988) .
The inhibition of peroxisomal fatty acid oxidation in hepatocytes by CPZ has been confirmed by Vamecq (1987) . He attributes the effect to COT inhibition. Our alternative explanation for the CPZ effect in whole cells is that the drug acts as an uncoupler of the mitochondrial oxidative phosphorylation and decreases the cell ATP concentration, a condition to which peroxisomes are more sensitive than are mitochondria (Leighton et al., 1987 ); yet we do not know at what level ATP is affecting peroxisomes selectively. In fact, with FCCP and other uncouplers, the selective inhibition of peroxisomes is readily seen (Leighton et al., 1987) . However, COT and CPT, which we have confirmed are sensitive to CPZ in vitro, are not affected by FCCP under the same conditions, (C. Necochea, C. Skorin & F. Leighton, unpublished work) . Therefore the hypothesis that the partial inhibition of COT would cause peroxisomal inhibition, and not stimulation, is not supported by the results mentioned above, nor by the present results.
The finding that peroxisomes contain a membrane ATPase (del Valle et al., 1988) , and the proposition that peroxisomes in situ exhibit an ATP-dependent structure-linked latency (Wolvetang et al., 1990) , in contrast with the well-characterized high permeability of the peroxisomal membrane in vitro (van Veldhoven et al., 1983; Labarca et al., 1986) , are elements that might be related to the proposed role ofcarnitine acyltransferases in transport through the peroxisomal membrane. Selective COT inhibitors, suitable for use with whole cells or animals, would allow exploration of the regulatory role proposed for this enzyme. In addition, they would help to establish the mechanism through which CPT I inhibitors counteract the characteristic induction of peroxisomal f-oxidation enzymes by clofibrate-like drugs (Hertz & Bar-Tana, 1987 International.
